India's Pharmaceutical Exports

Country Profile

Equatorial Guinea

Equatorial Guinea is a developing market for Indian pharmaceuticals — $2.69M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $43K. The compound annual growth rate since FY2016 stands at 8.8%.

🇬🇶 $2.69M · 2.3× growth since FY2016 · 8.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.69M
Exports FY2025–26 DGCIS
2.3×
Growth FY2016→2026
8.8%
CAGR FY2016→2026
97%
Medicines Share
3
Product Categories Supplied
Equatorial Guinea is a developing market for Indian pharmaceuticals — $2.69M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $43K. The compound annual growth rate since FY2016 stands at 8.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.60M (96.6%) Surgical & Hospital Supplies $47K (1.8%) Vaccines $43K (1.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Equatorial Guinea in the RBI overseas direct investment dataset (2011–2026).